Vuong Trieu

Chief Executive Officer at Oncotelic Therapeutics.

Raised on Oncotelic Therapeutics filings

$987K

of $13.2M offered across 2 Form D filings

Company

Biotech · Agoura Hills, CA

Antisense RNA drugs for cancer and viral disease

Antisense RNA drugs for cancer and viral disease

Oncotelic Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 22, 2026	Equity	$712K/ $712K	Form D
Dec 11, 2025	Equity	$275K/ $12.5M	Form D

Also named on Oncotelic Therapeutics filings